BCPS Exam 2024-2025 Questions &
Answers 100% Correct!!
____ is the most appropriate answer because there are no drug-drug interactions or
contraindications / cautions in HIV - ANSWERBictegravir
n patients with persistent neutropenic fever despite anti-pseudomonal coverage, what should be
considered? - ANSWERempiric antifungal therapy should be considered after 4 - 10 days
electrocautery - ANSWERWhich of the following therapies is most likely to result in a resolution rate
which approaches 100% in patients w/ external anogenital warts.?
preferred therapy for CMV retinitis? - ANSWERGanciclovir intravitreal injections plus valganciclovir
oral
bacterial vaginosis recommended treatment - ANSWERclindamycin or metronidazole
(i.e. Clindamycin 300 mg orally twice daily for 7 days)
recommended treatment regimen for pelvic inflammatory disease - ANSWERCeftriaxone 250 mg
intramuscularly x 1 dose plus doxycycline 100 mg orally twice daily for 14 days
vulvovaginal candidiasis teeatment - ANSWERClindamycin cream 2%, 5 g intravaginally at bedtime for
7 days
MedWatch - ANSWERpreferred route for healthcare professionals and patients to report suspected
adverse events to the FDA
FDA Form 3500A - ANSWERmechanism for reporting suspected adverse events, but is reserved for
use by user-facilities, importers, distributors, and manufacturers
, -reporting errors related to vaccines - ANSWERISMP VERP and VAERS
viral rhinosinusitis sx duration - ANSWER-peak at 3 days and may persist longer than 14 days but
usually decreases in severity by 10 days
-watchful waiting is recommended to avoid overuse of antibiotics as episodes are often self-limited
Malignant external otitis treatment - ANSWER- predominantly caused by Pseudomonas aeruginosa
-antipseudomonal antimicrobials are considered the mainstay of therapy.
Fidaxomicin - ANSWER-associated with decreased recurrence of Clostridioides difficile likely owing to
its narrow spectrum and minimal effect on normal colonic flora
duration of initial therapy for CDI? - ANSWER10 days with oral vancomycin or fidaxomicin
MRSA PCR - ANSWER-well-recognized tool for antimicrobial de-escalation as part of stewardship
initiatives given the high negative predictive value
MRSA nasal culture - ANSWER-used for surveillance and is not employed as a stewardship tool
Procalcitonin - ANSWER-useful in differentiating between viral and bacterial etiologies
-chronic kidney disease may cause an artificially high level leading to questionable interpretation and
potential continuation of inappropriate antimicrobials
Asymptomatic candiduria - ANSWER-common among hospitalized patients with an indwelling urinary
catheter and treatment is nt is not warranted
elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/c/FTC/TAF) - ANSWERElvitegravir is
only available in single-tablet regimen form; either as EVG/c/FTC/TAF or EVG/c/FTC/TDF. Therefore, it
is not possible to stock the single agents and "break up" the patient's regimen
Waterfall plot - ANSWER-Waterfall plot is ideal to represent secondary objectives.
Answers 100% Correct!!
____ is the most appropriate answer because there are no drug-drug interactions or
contraindications / cautions in HIV - ANSWERBictegravir
n patients with persistent neutropenic fever despite anti-pseudomonal coverage, what should be
considered? - ANSWERempiric antifungal therapy should be considered after 4 - 10 days
electrocautery - ANSWERWhich of the following therapies is most likely to result in a resolution rate
which approaches 100% in patients w/ external anogenital warts.?
preferred therapy for CMV retinitis? - ANSWERGanciclovir intravitreal injections plus valganciclovir
oral
bacterial vaginosis recommended treatment - ANSWERclindamycin or metronidazole
(i.e. Clindamycin 300 mg orally twice daily for 7 days)
recommended treatment regimen for pelvic inflammatory disease - ANSWERCeftriaxone 250 mg
intramuscularly x 1 dose plus doxycycline 100 mg orally twice daily for 14 days
vulvovaginal candidiasis teeatment - ANSWERClindamycin cream 2%, 5 g intravaginally at bedtime for
7 days
MedWatch - ANSWERpreferred route for healthcare professionals and patients to report suspected
adverse events to the FDA
FDA Form 3500A - ANSWERmechanism for reporting suspected adverse events, but is reserved for
use by user-facilities, importers, distributors, and manufacturers
, -reporting errors related to vaccines - ANSWERISMP VERP and VAERS
viral rhinosinusitis sx duration - ANSWER-peak at 3 days and may persist longer than 14 days but
usually decreases in severity by 10 days
-watchful waiting is recommended to avoid overuse of antibiotics as episodes are often self-limited
Malignant external otitis treatment - ANSWER- predominantly caused by Pseudomonas aeruginosa
-antipseudomonal antimicrobials are considered the mainstay of therapy.
Fidaxomicin - ANSWER-associated with decreased recurrence of Clostridioides difficile likely owing to
its narrow spectrum and minimal effect on normal colonic flora
duration of initial therapy for CDI? - ANSWER10 days with oral vancomycin or fidaxomicin
MRSA PCR - ANSWER-well-recognized tool for antimicrobial de-escalation as part of stewardship
initiatives given the high negative predictive value
MRSA nasal culture - ANSWER-used for surveillance and is not employed as a stewardship tool
Procalcitonin - ANSWER-useful in differentiating between viral and bacterial etiologies
-chronic kidney disease may cause an artificially high level leading to questionable interpretation and
potential continuation of inappropriate antimicrobials
Asymptomatic candiduria - ANSWER-common among hospitalized patients with an indwelling urinary
catheter and treatment is nt is not warranted
elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/c/FTC/TAF) - ANSWERElvitegravir is
only available in single-tablet regimen form; either as EVG/c/FTC/TAF or EVG/c/FTC/TDF. Therefore, it
is not possible to stock the single agents and "break up" the patient's regimen
Waterfall plot - ANSWER-Waterfall plot is ideal to represent secondary objectives.
